We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CureVac Expands European Manufacturing Network for its COVID 19 Vaccine
CureVac Expands European Manufacturing Network for its COVID 19 Vaccine
German drugmaker CureVac is scaling up its manufacturing capability in the European Union and plans to ship 300 million doses of its COVID-19 vaccine, CVnCoV, across the world next year and 600 million doses in 2022.